Lilly to introduce lower-priced insulin

March 5, 2019 by Chain Drug Review David Ricks, Eli Lilly and Co., Humalog (insulin lispro injection 100 units/mL) in the United States, insulin, insulin lispro, Lilly's chairman and chief executive officer Leading Headlines, Pharmacy, Supplier News

INDIANAPOLIS — Reinforcing their commitment to lower out-of-pocket costs for people who need insulin, Eli Lilly and Co. announced it will introduce a lower-priced version of Humalog (insulin lispro injection 100 units/mL) in the United States — providing people with diabetes an insulin option that will have a list price 50 percent lower than the current